BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs2300478
,
GATA1
,
G-protein-coupled receptor binding
,
Lung cancer
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LSD1i
Summary
General Info
Curated Studies
Most Correlated Studies
Glioblastoma tumor initiating cells with shRNA-mediated LSD1A knockdown or treated with DDP-38003
Explore Curated Studies Results
Literature
Most Relevant Literature
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells.
Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition.
JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.
Microfluidics guided by deep learning for cancer immunotherapy screening.
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-depend…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for LSD1i
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ